SHANGHAI and HONG KONG, April 23, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines...
Read More Details
Finally We wish PressBee provided you with enough information of ( Antengene to Present Latest Results From Two Clinical Studies at ASCO 2025 )
Also on site :
- Faith leaders challenge Texas law requiring Ten Commandments in classrooms
- Kremlin reveals how Putin will take part in BRICS summit
- 'M3GAN’ Star, 37, Details ‘Profoundly Scary’ Experience She Encountered: 'Huge Trauma'